Rajesh Gupta

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (22)

• Pandemic preparedness strategies must go beyond vaccines
  Science Translational Medicine 2023 DOI: 10.1126/scitranslmed.add3055
  +Save
• Monoclonal antibodies against rabies: current uses in prophylaxis and in therapy
  Current Opinion in Virology 2022 DOI: 10.1016/j.coviro.2022.101204
  +Save
• The power of one – in memoriam of Paul E. Farmer
  Journal of the International AIDS Society 2022 DOI: 10.1002/jia2.25903
  +Save
• Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
  The Lancet Infectious Diseases 2021 DOI: 10.1016/s1473-3099(21)00751-9
  +Save
• The need for global access to biomedical innovations during pandemics
  Nature Biotechnology 2021 DOI: 10.1038/s41587-021-00942-3
  +Save
• Advancing new tools for infectious diseases
  Science 2020 DOI: 10.1126/science.abe0773
  +Save
• Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial
  The Lancet Respiratory Medicine 2019 DOI: 10.1016/s2213-2600(18)30426-0
  +Save
• Compassionate use of delamanid in combination with bedaquiline for the treatment of multidrug-resistant tuberculosis
  European Respiratory Journal 2019 DOI: 10.1183/13993003.01154-2018
  +Save
• Delamanid: From discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)
  Tuberculosis 2018 DOI: 10.1016/j.tube.2018.04.008
  +Save
• Pan-tuberculosis regimens: re-framing the argument
  The Lancet Respiratory Medicine 2018 DOI: 10.1016/s2213-2600(18)30189-9
  +Save